Total Clarity Wealth Management, Inc. Bria Cell Therapeutics Corp. Transaction History

Total Clarity Wealth Management, Inc.

  • $278 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
BUY
$4.28 - $11.9 $13,631 - $37,901
3,185 New
3,185 $18,000
Q1 2022

Apr 29, 2022
SELL
$5.91 - $10.14 $93,484 - $160,394
-15,818 Closed
0 $0
Q4 2021

Feb 03, 2022
BUY
$7.1 - $10.61 $31,190 - $46,609
4,393 Added 38.45%
15,818 $131,000
Q3 2021

Oct 21, 2021
BUY
$4.4 - $9.28 $50,270 - $106,023
11,425 New
11,425 $93,000

Others Institutions Holding BCTX

# of Institutions
2
Shares Held
13
Call Options Held
0
Put Options Held
0
View Full List

About BriaCell Therapeutics Corp.

BCTX Quotes by TradingView
  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $16M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email